Cargando…
The Ethic of Access: An AIDS Activist Won Public Access to Experimental Therapies, and This Must Now Extend to Psychedelics for Mental Illness
If patients with mental illnesses are to be treated fairly in comparison with other categories of patients, they must be given access to promising experimental therapies, including psychedelics. The right of early access to promising therapies was advanced as an ethical principle by activist Larry K...
Autores principales: | Campbell, Morgan, Williams, Monnica T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287122/ https://www.ncbi.nlm.nih.gov/pubmed/34290631 http://dx.doi.org/10.3389/fpsyt.2021.680626 |
Ejemplares similares
-
Lifeboat ethics, risk, and therapeutic opportunity: an appeal for equitable psychedelic therapy access in the “high-risk” addiction patient
por: Black, Taylor
Publicado: (2023) -
Psychedelics and Other Psychoplastogens for Treating Mental Illness
por: Vargas, Maxemiliano V., et al.
Publicado: (2021) -
Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics
por: de Vos, Cato M. H., et al.
Publicado: (2021) -
The Readiness of Psychiatrists to Implement Psychedelic-Assisted Psychotherapy
por: Page, Lisa A., et al.
Publicado: (2021) -
Psychedelics and workplace harm
por: Viña, Sean Matthew, et al.
Publicado: (2023)